Skip to main content
Erschienen in: Endocrine 3/2017

09.07.2016 | Original Article

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome

verfasst von: Alessandro Prete, Rosa Maria Paragliola, Filomena Bottiglieri, Carlo Antonio Rota, Alfredo Pontecorvi, Roberto Salvatori, Salvatore Maria Corsello

Erschienen in: Endocrine | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Successful treatment of Cushing syndrome causes transient or permanent adrenal insufficiency deriving from endogenous hypercortisolism-induced hypothalamus–pituitary–adrenal–axis suppression. We analyzed pre-treatment factors potentially affecting the duration of adrenal insufficiency. We conducted a retrospective analysis on patients successfully treated for Cushing disease (15 patients) who underwent transsphenoidal surgery, and nonmalignant primary adrenal Cushing syndrome (31 patients) who underwent unilateral adrenalectomy, divided into patients with overt primary adrenal Cushing syndrome (14 patients) and subclinical primary adrenal Cushing syndrome (17 patients). Epidemiological data, medical history, and hormonal parameters depending on the etiology of hypercortisolism were collected and compared to the duration of adrenal insufficiency. The median duration of follow-up after surgery for Cushing disease and primary adrenal Cushing syndrome was 70 and 48 months, respectively. In the Cushing disease group, the median duration of adrenal insufficiency after transsphenoidal surgery was 15 months: younger age at diagnosis and longer duration of signs and symptoms of hypercortisolism before diagnosis and surgery were associated with longer duration of adrenal insufficiency. The median duration of adrenal insufficiency was 6 months for subclinical primary adrenal Cushing syndrome and 18.5 months for overt primary adrenal Cushing syndrome. The biochemical severity of hypercortisolism, the grade of hypothalamus–pituitary–adrenal–axis suppression, and treatment with ketoconazole before surgery accounted for longer duration of adrenal insufficiency. In patients with Cushing disease, younger age and delayed diagnosis and treatment predict longer need for glucocorticoid replacement therapy after successful transsphenoidal surgery. In patients with primary adrenal Cushing syndrome, the severity of hypercortisolism plays a primary role in influencing the duration of adrenal insufficiency after unilateral adrenalectomy.
Literatur
2.
Zurück zum Zitat L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008). doi:10.1210/jc.2008-0125 CrossRefPubMedPubMedCentral L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008). doi:10.​1210/​jc.​2008-0125 CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing’s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300–1308 (2015). doi:10.1210/jc.2014-3632 CrossRefPubMed C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing’s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300–1308 (2015). doi:10.​1210/​jc.​2014-3632 CrossRefPubMed
4.
Zurück zum Zitat T. Deutschbein, M. Broecker-Preuss, M.F. Hartmann, R. Althoff, S.A. Wudy, K. Mann, S. Petersenn, Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism. Horm. Metab. Res. 43(10), 714–719 (2011). doi:10.1055/s-0031-1286297 CrossRefPubMed T. Deutschbein, M. Broecker-Preuss, M.F. Hartmann, R. Althoff, S.A. Wudy, K. Mann, S. Petersenn, Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism. Horm. Metab. Res. 43(10), 714–719 (2011). doi:10.​1055/​s-0031-1286297 CrossRefPubMed
5.
Zurück zum Zitat S. Persichilli, J. Gervasoni, F. Iavarone, C. Zuppi, A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose. Clin. Chem. Lab. Med. 48(10), 1433–1437 (2010). doi:10.1515/CCLM.2010.282 CrossRefPubMed S. Persichilli, J. Gervasoni, F. Iavarone, C. Zuppi, A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose. Clin. Chem. Lab. Med. 48(10), 1433–1437 (2010). doi:10.​1515/​CCLM.​2010.​282 CrossRefPubMed
6.
Zurück zum Zitat M. Sereg, A. Szappanos, J. Toke, K. Karlinger, K. Feldman, E. Kaszper, I. Varga, E. Glaz, K. Racz, M. Toth, Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur. J. Endocrinol. 160(4), 647–655 (2009). doi:10.1530/EJE-08-0707 CrossRefPubMed M. Sereg, A. Szappanos, J. Toke, K. Karlinger, K. Feldman, E. Kaszper, I. Varga, E. Glaz, K. Racz, M. Toth, Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur. J. Endocrinol. 160(4), 647–655 (2009). doi:10.​1530/​EJE-08-0707 CrossRefPubMed
7.
Zurück zum Zitat M. Terzolo, S. Bovio, A. Pia, P.A. Conton, G. Reimondo, C. Dall’Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, B. Ambrosi, F. Mantero, Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur. J. Endocrinol. 153(2), 307–315 (2005). doi:10.1530/eje.1.01959 CrossRefPubMed M. Terzolo, S. Bovio, A. Pia, P.A. Conton, G. Reimondo, C. Dall’Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, B. Ambrosi, F. Mantero, Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur. J. Endocrinol. 153(2), 307–315 (2005). doi:10.​1530/​eje.​1.​01959 CrossRefPubMed
9.
Zurück zum Zitat F. Esposito, J.R. Dusick, P. Cohan, P. Moftakhar, D. McArthur, C. Wang, R.S. Swerdloff, D.F. Kelly, Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J. Clin. Endocrinol. Metab. 91(1), 7–13 (2006). doi:10.1210/jc.2005-1204 CrossRefPubMed F. Esposito, J.R. Dusick, P. Cohan, P. Moftakhar, D. McArthur, C. Wang, R.S. Swerdloff, D.F. Kelly, Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J. Clin. Endocrinol. Metab. 91(1), 7–13 (2006). doi:10.​1210/​jc.​2005-1204 CrossRefPubMed
10.
Zurück zum Zitat G. Di Dalmazi, C.M. Berr, M. Fassnacht, F. Beuschlein, M. Reincke, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature. J. Clin. Endocrinol. Metab. 99(8), 2637–2645 (2014). doi:10.1210/jc.2014-1401 CrossRefPubMed G. Di Dalmazi, C.M. Berr, M. Fassnacht, F. Beuschlein, M. Reincke, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature. J. Clin. Endocrinol. Metab. 99(8), 2637–2645 (2014). doi:10.​1210/​jc.​2014-1401 CrossRefPubMed
11.
Zurück zum Zitat P.A. Fitzgerald, D.C. Aron, J.W. Findling, R.M. Brooks, C.B. Wilson, P.H. Forsham, J.B. Tyrrell, Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54(2), 413–422 (1982). doi:10.1210/jcem-54-2-413 CrossRefPubMed P.A. Fitzgerald, D.C. Aron, J.W. Findling, R.M. Brooks, C.B. Wilson, P.H. Forsham, J.B. Tyrrell, Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54(2), 413–422 (1982). doi:10.​1210/​jcem-54-2-413 CrossRefPubMed
12.
Zurück zum Zitat A.R. Hermus, G.F. Pieters, G.J. Pesman, E. Meijer, A.G. Smals, T.J. Benraad, P.W. Kloppenborg, Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing’s disease?. J. Endocrinol. Invest. 10(4), 365–369 (1987). doi:10.1007/BF03348149 CrossRefPubMed A.R. Hermus, G.F. Pieters, G.J. Pesman, E. Meijer, A.G. Smals, T.J. Benraad, P.W. Kloppenborg, Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing’s disease?. J. Endocrinol. Invest. 10(4), 365–369 (1987). doi:10.​1007/​BF03348149 CrossRefPubMed
13.
Zurück zum Zitat J. Flitsch, D.K. Ludecke, U.J. Knappe, W. Saeger, Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing’s disease. Exp. Clin. Endocrinol. Diabetes 107(3), 183–189 (1999). doi:10.1055/s-0029-1212095 CrossRefPubMed J. Flitsch, D.K. Ludecke, U.J. Knappe, W. Saeger, Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing’s disease. Exp. Clin. Endocrinol. Diabetes 107(3), 183–189 (1999). doi:10.​1055/​s-0029-1212095 CrossRefPubMed
14.
Zurück zum Zitat M. Lodish, S.V. Dunn, N. Sinaii, M.F. Keil, C.A. Stratakis, Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing’s disease. J. Clin. Endocrinol. Metab. 97(5), 1483–1491 (2012). doi:10.1210/jc.2011-2325 CrossRefPubMedPubMedCentral M. Lodish, S.V. Dunn, N. Sinaii, M.F. Keil, C.A. Stratakis, Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing’s disease. J. Clin. Endocrinol. Metab. 97(5), 1483–1491 (2012). doi:10.​1210/​jc.​2011-2325 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s disease survey group. J. Clin. Endocrinol. Metab. 80(11), 3114–3120 (1995). doi:10.1210/jcem.80.11.7593411 PubMed D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s disease survey group. J. Clin. Endocrinol. Metab. 80(11), 3114–3120 (1995). doi:10.​1210/​jcem.​80.​11.​7593411 PubMed
16.
Zurück zum Zitat N. Sonino, M. Zielezny, G.A. Fava, F. Fallo, M. Boscaro, Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J. Clin. Endocrinol. Metab. 81(7), 2647–2652 (1996). doi:10.1210/jcem.81.7.8675592 PubMed N. Sonino, M. Zielezny, G.A. Fava, F. Fallo, M. Boscaro, Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J. Clin. Endocrinol. Metab. 81(7), 2647–2652 (1996). doi:10.​1210/​jcem.​81.​7.​8675592 PubMed
17.
Zurück zum Zitat S.H. Roerink, M.A. Wagenmakers, J.W. Smit, E.F. van Rossum, R.T. Netea-Maier, T.S. Plantinga, A.R. Hermus, Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome. Endocrine (2016). doi:10.1007/s12020-016-0883-z S.H. Roerink, M.A. Wagenmakers, J.W. Smit, E.F. van Rossum, R.T. Netea-Maier, T.S. Plantinga, A.R. Hermus, Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome. Endocrine (2016). doi:10.​1007/​s12020-016-0883-z
18.
Zurück zum Zitat O. Ragnarsson, C.A. Glad, P. Berglund, R. Bergthorsdottir, D.N. Eder, G. Johannsson, Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing’s syndrome in remission. J. Clin. Endocrinol. Metab. 99(9), E1803–1807 (2014). doi:10.1210/jc.2014-1906 CrossRefPubMed O. Ragnarsson, C.A. Glad, P. Berglund, R. Bergthorsdottir, D.N. Eder, G. Johannsson, Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing’s syndrome in remission. J. Clin. Endocrinol. Metab. 99(9), E1803–1807 (2014). doi:10.​1210/​jc.​2014-1906 CrossRefPubMed
19.
Zurück zum Zitat L. Trementino, G. Appolloni, C. Concettoni, M. Cardinaletti, M. Boscaro, G. Arnaldi, Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing’s syndrome. Eur. J. Endocrinol. 166(1), 35–42 (2012). doi:10.1530/EJE-11-0722 CrossRefPubMed L. Trementino, G. Appolloni, C. Concettoni, M. Cardinaletti, M. Boscaro, G. Arnaldi, Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing’s syndrome. Eur. J. Endocrinol. 166(1), 35–42 (2012). doi:10.​1530/​EJE-11-0722 CrossRefPubMed
20.
Zurück zum Zitat M.P. Ricciato, V. Di Donna, G. Perotti, A. Pontecorvi, R. Bellantone, S.M. Corsello, The role of adrenal scintigraphy in the diagnosis of subclinical Cushing’s syndrome and the prediction of post-surgical hypoadrenalism. World J. Surg. 38(6), 1328–1335 (2014). doi:10.1007/s00268-014-2482-6 PubMed M.P. Ricciato, V. Di Donna, G. Perotti, A. Pontecorvi, R. Bellantone, S.M. Corsello, The role of adrenal scintigraphy in the diagnosis of subclinical Cushing’s syndrome and the prediction of post-surgical hypoadrenalism. World J. Surg. 38(6), 1328–1335 (2014). doi:10.​1007/​s00268-014-2482-6 PubMed
21.
Zurück zum Zitat L.M. Fig, M.D. Gross, B. Shapiro, D.A. Ehrmann, J.E. Freitas, D.E. Schteingart, G.M. Glazer, I.R. Francis, Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. Ann. Intern. Med. 109(7), 547–553 (1988)CrossRefPubMed L.M. Fig, M.D. Gross, B. Shapiro, D.A. Ehrmann, J.E. Freitas, D.E. Schteingart, G.M. Glazer, I.R. Francis, Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. Ann. Intern. Med. 109(7), 547–553 (1988)CrossRefPubMed
22.
Zurück zum Zitat D. Rubello, C. Bui, D. Casara, M.D. Gross, L.M. Fig, B. Shapiro, Functional scintigraphy of the adrenal gland. Eur. J. Endocrinol. 147(1), 13–28 (2002)CrossRefPubMed D. Rubello, C. Bui, D. Casara, M.D. Gross, L.M. Fig, B. Shapiro, Functional scintigraphy of the adrenal gland. Eur. J. Endocrinol. 147(1), 13–28 (2002)CrossRefPubMed
24.
Zurück zum Zitat F. Donadio, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Carletto, M. Castellani, L. Dellavedova, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J. Endocrinol. Invest. 32(7), 576–580 (2009). doi:10.3275/6360 CrossRefPubMed F. Donadio, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Carletto, M. Castellani, L. Dellavedova, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J. Endocrinol. Invest. 32(7), 576–580 (2009). doi:10.​3275/​6360 CrossRefPubMed
25.
26.
Zurück zum Zitat J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin. Endocrinol. 43(5), 545–550 (1995)CrossRef J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin. Endocrinol. 43(5), 545–550 (1995)CrossRef
27.
Zurück zum Zitat F. Pecori Giraldi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J. Clin. Endocrinol. Metab. 92(11), 4123–4129 (2007). doi:10.1210/jc.2007-0596 CrossRefPubMed F. Pecori Giraldi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J. Clin. Endocrinol. Metab. 92(11), 4123–4129 (2007). doi:10.​1210/​jc.​2007-0596 CrossRefPubMed
28.
Zurück zum Zitat J. Shen, M. Sun, B. Zhou, J. Yan, Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy?. Eur. J. Endocrinol. 171(4), 421–431 (2014). doi:10.1530/EJE-14-0345 CrossRefPubMed J. Shen, M. Sun, B. Zhou, J. Yan, Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy?. Eur. J. Endocrinol. 171(4), 421–431 (2014). doi:10.​1530/​EJE-14-0345 CrossRefPubMed
29.
Zurück zum Zitat M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, Italian Association of Clinical, E.: AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851–870 (2011). doi:10.1530/EJE-10-1147 CrossRefPubMed M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, Italian Association of Clinical, E.: AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851–870 (2011). doi:10.​1530/​EJE-10-1147 CrossRefPubMed
30.
Zurück zum Zitat C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, I. Chiodini, Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. Eur. J. Endocrinol. 162(1), 91–99 (2010). doi:10.1530/EJE-09-0775 CrossRefPubMed C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, I. Chiodini, Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. Eur. J. Endocrinol. 162(1), 91–99 (2010). doi:10.​1530/​EJE-09-0775 CrossRefPubMed
31.
Zurück zum Zitat S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157(6), 725–731 (2007). doi:10.1530/EJE-07-0424 CrossRefPubMed S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157(6), 725–731 (2007). doi:10.​1530/​EJE-07-0424 CrossRefPubMed
33.
Zurück zum Zitat N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, C.H. Shackleton, Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121(3-5), 496–504 (2010). doi:10.1016/j.jsbmb.2010.04.010 CrossRefPubMedPubMedCentral N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, C.H. Shackleton, Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121(3-5), 496–504 (2010). doi:10.​1016/​j.​jsbmb.​2010.​04.​010 CrossRefPubMedPubMedCentral
Metadaten
Titel
Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome
verfasst von
Alessandro Prete
Rosa Maria Paragliola
Filomena Bottiglieri
Carlo Antonio Rota
Alfredo Pontecorvi
Roberto Salvatori
Salvatore Maria Corsello
Publikationsdatum
09.07.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1007-5

Weitere Artikel der Ausgabe 3/2017

Endocrine 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.